Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-08

Clinical Trial Update: TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I) [NA]

View source ↗

Summary

This clinical trial update reports that the TRIcvalve biCAVal Valve System for severe tricuspid regurgitation (TRICAV-I) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: P+F Products + Features USA Inc. | Conditions: Tricuspid Regurgitation, Tricuspid Valve Disease | NA | Status: RECRUITING